Get started
NanoViricides, Inc.NN

NanoViricides, Inc.

1.34USDR
0.000.00%
Last update at Jun 18, 23:53 GMT
USD
No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals Options

NNVC chart


Full chart

NNVC upcoming earnings


Next report date
≈
September 3
Report period
Q4 2025
EPS estimate
−0.20 USD
Revenue estimate
—

Key stats


Market capitalization
‪21.54 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.70 USD
Net income (FY)
‪−8.29 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪15.49 M‬
Beta (1Y)
0.45

Employees


Employees (FY)
7
Change (1Y)
0
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.18 M‬ USD

About NanoViricides, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Anil R. Diwan
Website
nanoviricides.com
Headquarters
Shelton
Founded
2005
FIGI
BBG000C0WN63
NanoViricides, Inc. is a clinical stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.

Financials


Performance
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
‪‪−3.20 M‬‬
‪‪−2.40 M‬‬
‪‪−1.60 M‬‬
‪‪−800.00 K‬‬
‪0.00‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−2.40 M‬‬
‪‪−1.80 M‬‬
‪‪−1.20 M‬‬
‪‪−600.00 K‬‬
‪0.00‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−2.40 M‬‬
‪‪−1.80 M‬‬
‪‪−1.20 M‬‬
‪‪−600.00 K‬‬
‪0.00‬
Debt level and coverage
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
‪‪−5.00 M‬‬
‪‪−2.50 M‬‬
‪0.00‬
‪‪2.50 M‬‬
‪‪5.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:Sep 3, 2025
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
‪−0.32‬
‪−0.24‬
‪−0.16‬
‪−0.08‬
‪0.00‬
Estimate

NNVC news



No news here

Looks like there's nothing to report right now

Reload

Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of NNVC is 1.34 USD — it hasn't changed in the past 24 hours. Watch NanoViricides, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange NanoViricides, Inc. stocks are traded under the ticker NNVC.
NNVC stock has fallen by −14.65% compared to the previous week, the month change is a −8.84% fall, over the last year NanoViricides, Inc. has showed a −28.34% decrease.
NNVC reached its all-time high on Mar 21, 2006 with the price of 262.50 USD, and its all-time low was 0.94 USD and was reached on Apr 9, 2025. View more price dynamics on NNVC chart.
See other stocks reaching their highest and lowest prices.
NNVC stock is 8.80% volatile and has beta coefficient of 0.45. Track NanoViricides, Inc. stock price on the chart and check out the list of the most volatile stocks — is NanoViricides, Inc. there?
Today NanoViricides, Inc. has the market capitalization of ‪21.54 M‬, it has decreased by −11.84% over the last week.
Yes, you can track NanoViricides, Inc. financials in yearly and quarterly reports right on TradingView.
NanoViricides, Inc. is going to release the next earnings report on Sep 3, 2025. Keep track of upcoming events with our Earnings Calendar.
NNVC net income for the last quarter is ‪−2.22 M‬ USD, while the quarter before that showed ‪−2.03 M‬ USD of net income which accounts for −9.34% change. Track more NanoViricides, Inc. financial stats to get the full picture.
No, NNVC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 19, 2025, the company has 7 employees. See our rating of the largest employees — is NanoViricides, Inc. on this list?
Like other stocks, NNVC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NanoViricides, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NanoViricides, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NanoViricides, Inc. stock shows the sell signal. See more of NanoViricides, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.